NO327301B1 - Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt - Google Patents

Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt Download PDF

Info

Publication number: NO327301B1
Authority: NO; Norway
Prior art keywords: astaxanthin; mastitis; manufacture; drug; treatment
Prior art date: 1997-12-16

Application number

NO20003042A

Other languages

English (en)

Norwegian (no)

Other versions

NO20003042L (no

NO20003042D0 (no

Inventor

Ake Lignell

Johan Inborr

Original Assignee

Astracarotene Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-16

Filing date

2000-06-14

Publication date

2009-06-02

2000-06-14 Application filed by Astracarotene Ab filed Critical Astracarotene Ab

2000-06-14 Publication of NO20003042L publication Critical patent/NO20003042L/no

2000-06-14 Publication of NO20003042D0 publication Critical patent/NO20003042D0/no

2009-06-02 Publication of NO327301B1 publication Critical patent/NO327301B1/no

Links

JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims description 25
235000013793 astaxanthin Nutrition 0.000 title claims description 25
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims description 25
229940022405 astaxanthin Drugs 0.000 title claims description 25
239000001168 astaxanthin Substances 0.000 title claims description 25
238000004519 manufacturing process Methods 0.000 title claims description 11
239000003814 drug Substances 0.000 title claims description 9
208000004396 mastitis Diseases 0.000 title claims description 8
229940079593 drug Drugs 0.000 title description 5
238000011282 treatment Methods 0.000 title description 2
241000195493 Cryptophyta Species 0.000 claims description 8
241000168525 Haematococcus Species 0.000 claims description 3
241000282412 Homo Species 0.000 claims description 3
235000014113 dietary fatty acids Nutrition 0.000 claims description 3
229930195729 fatty acid Natural products 0.000 claims description 3
239000000194 fatty acid Substances 0.000 claims description 3
150000004665 fatty acids Chemical class 0.000 claims description 3
238000011321 prophylaxis Methods 0.000 claims description 3
230000037396 body weight Effects 0.000 claims description 2
235000013312 flour Nutrition 0.000 claims description 2
235000013336 milk Nutrition 0.000 description 6
239000008267 milk Substances 0.000 description 6
210000004080 milk Anatomy 0.000 description 6
241000283690 Bos taurus Species 0.000 description 3
235000013365 dairy product Nutrition 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
241001465754 Metazoa Species 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
235000013305 food Nutrition 0.000 description 2
235000001674 Agaricus brunnescens Nutrition 0.000 description 1
241000238017 Astacoidea Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
241000168517 Haematococcus lacustris Species 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000035752 Live birth Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
230000003064 anti-oxidating effect Effects 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
235000021466 carotenoid Nutrition 0.000 description 1
150000001747 carotenoids Chemical class 0.000 description 1
239000000969 carrier Substances 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
238000003977 dairy farming Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
235000020774 essential nutrients Nutrition 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000003925 fat Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000011868 grain product Nutrition 0.000 description 1
230000003862 health status Effects 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000006651 lactation Effects 0.000 description 1
210000005075 mammary gland Anatomy 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
229940126601 medicinal product Drugs 0.000 description 1
239000000203 mixture Substances 0.000 description 1
210000002445 nipple Anatomy 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
235000008210 xanthophylls Nutrition 0.000 description 1
150000003735 xanthophylls Chemical class 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Oncology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Pregnancy & Childbirth (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

NO20003042A 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt NO327301B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9704693A SE511237C2 (sv)	1997-12-16	1997-12-16	Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
PCT/SE1998/002279 WO1999030701A1 (en)	1997-12-16	1998-12-10	Method of the prophylactic treatment of mastitis

Publications (3)

Publication Number	Publication Date
NO20003042L NO20003042L (no)	2000-06-14
NO20003042D0 NO20003042D0 (no)	2000-06-14
NO327301B1 true NO327301B1 (no)	2009-06-02

Family

ID=20409414

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003042A NO327301B1 (no)	1997-12-16	2000-06-14	Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Country Status (12)

Country	Link
US (1)	US6335015B1 (de)
EP (1)	EP1049460B1 (de)
JP (1)	JP2002508318A (de)
AR (1)	AR017877A1 (de)
AT (1)	ATE239457T1 (de)
AU (1)	AU743198B2 (de)
CA (1)	CA2314170C (de)
DE (1)	DE69814467D1 (de)
NO (1)	NO327301B1 (de)
NZ (1)	NZ504801A (de)
SE (1)	SE511237C2 (de)
WO (1)	WO1999030701A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9903336D0 (sv) *	1999-09-17	1999-09-17	Astacarotene Ab	DNA construct and its use
SE9903619D0 (sv) *	1999-10-07	1999-10-07	Astacarotene Ab	Use and method of treatment
US7521584B2 (en)	2002-07-29	2009-04-21	Cardax Pharmaceuticals, Inc.	Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7145025B2 (en) *	2002-07-29	2006-12-05	Hawaii Biotech, Inc.	Structural carotenoid analogs for the inhibition and amelioration of disease
US20050059635A1 (en) *	2002-07-29	2005-03-17	Lockwood Samuel Fournier	Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) *	2002-07-29	2005-06-30	Lockwood Samuel F.	Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7320997B2 (en)	2002-07-29	2008-01-22	Cardax Pharmaceuticals, Inc.	Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en)	2002-07-29	2010-05-25	Cardax Pharmaceuticals, Inc.	Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en)	2002-07-29	2008-03-18	Cardax Pharmaceuticals, Inc.	Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) *	2002-07-29	2008-05-20	Cardax Pharmaceuticals, Inc.	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en)	2002-07-29	2010-07-27	Cardax Pharmaceuticals, Inc.	Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050148517A1 (en) *	2002-07-29	2005-07-07	Lockwood Samuel F.	Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) *	2004-04-14	2006-03-16	Lockwood Samuel F	Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) *	2004-04-14	2005-11-03	Hawaii Biotech, Inc.	Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
MX2007003773A (es)	2004-09-28	2009-01-19	Chemaphor Inc	Composiciones y metodos para promover ganancia de peso y conversion de alimentacion.
WO2006039685A2 (en) *	2004-10-01	2006-04-13	Hawaii Biotech, Inc.	Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives
DK2214656T3 (en)	2007-10-26	2019-03-25	Avivagen Inc	COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE
WO2010124392A1 (en) *	2009-04-30	2010-11-04	Chemaphor Inc.	Methods, compositions, and kits for the treatment of inflammatory conditions
US10456369B2 (en)	2009-04-30	2019-10-29	Avivagen Inc.	Methods and compositions for improving the health of animals
US20230079333A1 (en) *	2020-02-18	2023-03-16	Avivagen Inc.	Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2619491B2 (ja)	1988-08-11	1997-06-11	サントリー株式会社	アスタキサンチン含有組成物
CA2210957A1 (en) *	1995-02-03	1996-08-08	Basf Aktiengesellschaft	The use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja)	1995-10-26	1997-05-13	Suntory Ltd	抗ストレス組成物
SE506191C2 (sv)	1996-03-27	1997-11-17	Astacarotene Ab	Medel och sätt för att öka produktionen av/hos däggdjur

1997
- 1997-12-16 SE SE9704693A patent/SE511237C2/sv not_active IP Right Cessation
1998
- 1998-12-10 WO PCT/SE1998/002279 patent/WO1999030701A1/en not_active Ceased
- 1998-12-10 JP JP2000538684A patent/JP2002508318A/ja active Pending
- 1998-12-10 AT AT98963702T patent/ATE239457T1/de not_active IP Right Cessation
- 1998-12-10 CA CA002314170A patent/CA2314170C/en not_active Expired - Fee Related
- 1998-12-10 US US09/589,594 patent/US6335015B1/en not_active Expired - Lifetime
- 1998-12-10 DE DE69814467T patent/DE69814467D1/de not_active Expired - Lifetime
- 1998-12-10 EP EP98963702A patent/EP1049460B1/de not_active Expired - Lifetime
- 1998-12-10 AU AU18972/99A patent/AU743198B2/en not_active Ceased
- 1998-12-10 NZ NZ504801A patent/NZ504801A/en not_active IP Right Cessation
- 1998-12-16 AR ARP980106418A patent/AR017877A1/es unknown
2000
- 2000-06-14 NO NO20003042A patent/NO327301B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1049460B1 (de)	2003-05-07
SE9704693L (sv)	1999-06-17
US6335015B1 (en)	2002-01-01
SE9704693D0 (sv)	1997-12-16
CA2314170A1 (en)	1999-06-24
NZ504801A (en)	2002-05-31
AU743198B2 (en)	2002-01-24
NO20003042L (no)	2000-06-14
DE69814467D1 (de)	2003-06-12
JP2002508318A (ja)	2002-03-19
CA2314170C (en)	2008-01-29
AR017877A1 (es)	2001-10-24
NO20003042D0 (no)	2000-06-14
ATE239457T1 (de)	2003-05-15
EP1049460A1 (de)	2000-11-08
AU1897299A (en)	1999-07-05
SE511237C2 (sv)	1999-08-30
WO1999030701A1 (en)	1999-06-24

Legal Events

Date	Code	Title	Description
2019-01-14	MK1K	Patent expired

Publication	Publication Date	Title
US6335015B1 (en)	2002-01-01	Method of the prophylactic treatment of mastitis
Dashko et al.	2020	Treatment of purulent-necrotic diseases of the distal region of limbs complicated by bacterial microflora in cattle
AU747077B2 (en)	2002-05-09	Immunoglobulin-rich milk, production and use thereof
JP3897978B2 (ja)	2007-03-28	精液の生産増加方法およびその質の改良方法
Açikgöz et al.	2016	Using facilities of apilarnil (bee drone larvae) in poultry nutrition
Borum	2024	Apitherapy and applications in veterinary medicine
RU2450531C2 (ru)	2012-05-20	Способ повышения продуктивности молодняка сельскохозяйственных животных
Abdel-Rahman et al.	2024	Effect of Some Nutraceuticals Such as Dates Fruits, L-Carnitine, Fenugreek, Royal Jelly and Silymarin on the Pregnancy and Lactational Performance of Rabbits
RU2259198C1 (ru)	2005-08-27	Способ повышения продуктивности крупного рогатого скота
RU2423109C1 (ru)	2011-07-10	Средство для нормализации обменных процессов у животных
TW200930395A (en)	2009-07-16	Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
RU2836314C1 (ru)	2025-03-12	Способ повышения иммунитета цыплят-бройлеров на фоне вакцинального стресса
Bojkovski et al.	2025	Retrospective of Clinical Pathology of Herd Pigs in Extensive and Intensive Breeding
Topuria	2024	Influence of the Probiotic Preparation Immunofloor on the Immune Status of Broiler Chickens
RU2317823C1 (ru)	2008-02-27	Способ повышения естественной резистентности сельскохозяйственных животных
Prasad et al.	2023	Concept of modern animal Management-Farm Animal Welfare
Al_Galiby et al.	2022	Studying the effect of giving doses of different levels of the group of vitamins AD3E on some productive and doll traits For young male goats the local
RU2227026C1 (ru)	2004-04-20	Способ профилактики и лечения гепатодистрофии поросят
RU2635513C1 (ru)	2017-11-13	Способ лечения гипотиреоза у крупного рогатого скота
RU2668535C2 (ru)	2018-10-01	Способ профилактики маститов у высокопродуктивных коров
WO2013019145A2 (ru)	2013-02-07	Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных
Zuhrabov et al.	2020	Ecological Bases of Ethiology and Therapy of Hemolytic Anemia in Cattle During Piroplasmosis
MD1530Z (ro)	2021-12-31	Metodă de profilaxie a dispepsiei imunodeficitare la viţei
RU2333761C1 (ru)	2008-09-20	Способ повышения молочной продуктивности сухостойных коров
RU2471493C2 (ru)	2013-01-10	Биогенный стимулятор и способ его изготовления